New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. ÌýYou can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
WELCOME BACK
Quantitative Nodal Burden and Mortality Across Solid Cancers.
ÌÇÐÄ´«Ã½
Quantitative Nodal Burden and Mortality Across Solid Cancers. Journal of the National Cancer Institute Nguyen, A. T., Luu, M., Nguyen, V. P., Lu, D. J., Shiao, S. L., Kamrava, M., Atkins, K. M., Mita, A. C., Scher, K. S., Spratt, D. E., Faries, M. B., Daskivich, T. J., Lin, D. C., Chen, M. M., Clair, J. M., Sandler, H. M., Ho, A. S., Zumsteg, Z. S. 2022; 114 (7): 1003-1011Abstract
Nodal staging systems vary substantially across solid tumors, implying heterogeneity in the behavior of nodal variables in various contexts. We hypothesized, in contradiction to this, that metastatic lymph node (LN) number is a universal and dominant predictor of outcome across solid tumors.We performed a retrospective cohort analysis of 1?304?498 patients in the National Cancer Database undergoing surgery between 2004 and 2015 across 16 solid cancer sites. Multivariable Cox regression analyses were constructed using restricted cubic splines to model the association between nodal number and mortality. Recursive partitioning analysis (RPA) was used to derive nodal classification systems for each solid cancer based on metastatic LN count. The reproducibility of these findings was assessed in 1?969?727 patients from the Surveillance, Epidemiology, and End Results registry. Two-sided tests were used for all statistical analyses.Consistently across disease sites, mortality risk increased continuously with increasing number of metastatic LNs (P?
View details for
View details for
View details for